Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Leases (2019 - 2024)

Historic Current Leases for Sanofi (SNY) over the last 7 years, with Q2 2025 value amounting to $285.3 million.

  • Sanofi's Current Leases fell 505.83% to $285.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $285.3 million, marking a year-over-year decrease of 505.83%. This contributed to the annual value of $278.9 million for FY2024, which is 624.22% down from last year.
  • As of Q2 2025, Sanofi's Current Leases stood at $285.3 million, which was down 505.83% from $278.9 million recorded in Q4 2024.
  • In the past 5 years, Sanofi's Current Leases registered a high of $307.7 million during Q4 2021, and its lowest value of $246.5 million during Q2 2022.
  • Its 5-year average for Current Leases is $285.6 million, with a median of $285.3 million in 2025.
  • Its Current Leases has fluctuated over the past 5 years, first crashed by 1713.37% in 2022, then surged by 1176.83% in 2023.
  • Sanofi's Current Leases (Quarter) stood at $307.7 million in 2021, then dropped by 8.16% to $282.6 million in 2022, then rose by 4.7% to $295.9 million in 2023, then fell by 5.74% to $278.9 million in 2024, then rose by 2.28% to $285.3 million in 2025.
  • Its last three reported values are $285.3 million in Q2 2025, $278.9 million for Q4 2024, and $300.5 million during Q2 2024.